Latest Videos Archives

Intermediate-Risk NMIBC/BCG Naïve: Treatment of Choice

Leonard G. Gomella, MD, FACS, explores bladder cancer treatment, particularly in the context of intermediate-risk, BCG-naïve disease.

Posted by Jay Simhan, MD, FACS | May 2025

Jay Simhan, MD, FACS, examines the challenges of penile implants in patients with refractory erectile dysfunction and Peyronie’s disease.

Clinical trials corner issue 11(1) Abstract: Dear Readers, In this issue, we highlight recently...

Jeffrey J. Tosoian, MD, MPH, introduces the MyProstateScore 2.0 test as a non-invasive urine-based diagnostic tool for prostate cancer.

Michael A. O’Donnell, MD, discusses BCG’s role as the standard treatment for non-muscle invasive bladder cancer (NMIBC).